Results 201 to 210 of about 32,522 (253)

Measurable residual disease (MRD) as a surrogate end point for clinical drug approval in acute myeloid leukemia (AML): Perspectives from the MRD Partnership and Alliance in AML Clinical Treatment Consortium. [PDF]

open access: yesCancer
Boyiadzis M   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy